↓ Skip to main content

Dove Medical Press

Article Metrics

Melanoma vaccines: trials and tribulations

Overview of attention for article published in Vaccine : Development and Therapy, October 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

twitter
1 tweeter
googleplus
1 Google+ user
video
1 video uploader

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
5 Mendeley
Title
Melanoma vaccines: trials and tribulations
Published in
Vaccine : Development and Therapy, October 2013
DOI 10.2147/vdt.s32396
Authors

Robert Dillman

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 40%
Student > Bachelor 1 20%
Student > Doctoral Student 1 20%
Student > Ph. D. Student 1 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 40%
Chemistry 1 20%
Medicine and Dentistry 1 20%
Unknown 1 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2013.
All research outputs
#7,165,888
of 12,706,217 outputs
Outputs from Vaccine : Development and Therapy
#11
of 23 outputs
Outputs of similar age
#78,823
of 177,324 outputs
Outputs of similar age from Vaccine : Development and Therapy
#1
of 2 outputs
Altmetric has tracked 12,706,217 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23 research outputs from this source. They receive a mean Attention Score of 2.3. This one scored the same or higher as 12 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,324 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them